Acta Scientific Gastrointestinal Disorders (ASGIS)(ISSN: 2582-1091)

Review Article Volume 4 Issue 9

Eosinophilic Esophagitis

Aimun Raees and Wasim Jafri*

Department of Medicine Gastroenterology, Aga Khan University, Karachi, Pakistan

*Corresponding Author: Wasim Jafri, Department of Medicine Gastroenterology, Aga Khan University, Karachi, Pakistan.

Received: July 13, 2021; Published: August 16, 2021


Eosinophilic Esophagitis (EoE) is a long-standing, relapsing immune-mediated esophageal disorder, facilitated by atopy, resulting in dysphagia and esophageal strictures. The prevalence has been leaping in the last few decades consistent with the enhanced understanding of the disease. It occurs in people from all ages but children and young males are especially affected. A wide spectrum of factors has been associated with it, including genetic and environmental risk factors. In atopic individuals, interaction of allergens with the esophageal epithelium generates a T-helper cells type2 driven immune response, which leads to the activation of inflammatory cytokines which in turn induce various genes causing formation and recruitment of eosinophils as well as mast cells setting in a chronic inflammatory process. Diagnosis is made on typical clinical, endoscopic and histological factors. Therapeutic modalities range from dietary restriction to corticosteroid therapy. Endoscopic intervention may be needed for patients presenting with esophageal strictures. Recently, biological agents have also been under trials for its treatment but there is no FDA approved drug therapy available as yet. It is a relatively new disorder that is constantly under evolution in terms of diagnostic and therapeutic fields.

Keywords: Eosinophilic Esophagitis; Dysphagia; Food Impaction; Esophageal Stricture; Atopic Disorder


  1. Attwood SE., et al. “Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome”. Digestive Diseases and Sciences 38 (1993): 109-116.
  2. Straumann A., et al. “[Idiopathic eosinophilic esophagitis: a frequently overlooked disease with typical clinical aspects and discrete endoscopic findings]”. Schweizerische Medizinische Wochenschrift 124 (1994): 1419-1429.
  3. Benninger MS., et al. “Prevalence of atopic disease in patients with eosinophilic esophagitis”. International Forum of Allergy and Rhinology 7 (2017): 757-762.
  4. Navarro P., et al. “Systematic review with meta-analysis: the growing incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies”. Alimentary Pharmacology and Therapeutics 49 (2019): 1116-1125.
  5. Mansoor E and Cooper GS. “The 2010-2015 prevalence of eosinophilic esophagitis in the USA: a population-based study”. Digestive Diseases and Sciences 61 (2016): 2928-2934.
  6. Dellon ES and Hirano I. “Epidemiology and Natural History of Eosinophilic Esophagitis”. Gastroenterology 154 (2018): 319-332.e3.
  7. Ruffner Melanie A., et al. “Pathophysiology of eosinophilic esophagitis: recent advances and their clinical implications”. Expert Review of Clinical Immunology1 (2019): 83-95.
  8. Litosh VA., et al. “Calpain-14 and its association with eosinophilic esophagitis”. The Journal of Allergy and Clinical Immunology 139 (2017): 1762-1771.e7.
  9. Kottyan L and Rothenberg M. “Genetics of eosinophilic esophagitis”. Mucosal Immunology 10 (2017): 580-588.
  10. Sherrill JD., et al. “Desmoglein-1 regulates esophageal epithelial barrier function and immune responses in eosinophilic esophagitis”. Mucosal Immunology 7 (2014): 718-729.
  11. Sperry Sarah LW., et al. “Influence of race and gender on the presentation of eosinophilic esophagitis”. The American Journal of Gastroenterology2 (2012): 215.
  12. Votto Martina., et al. “Early Life Risk Factors in Pediatric EoE: Could We Prevent This Modern Disease?” Frontiers in Pediatrics 8 (2020): 263.
  13. Green Daniel J., et al. “The role of environmental exposures in the etiology of eosinophilic esophagitis: a systematic review”. Mayo Clinic Proceedings10 (2015).
  14. Jensen ET., et al. “Seasonal variation in detection of oesophageal eosinophilia and eosinophilic oesophagitis”. Alimentary Pharmacology and Therapeutics 42 (2015): 461-469.
  15. Kidambi T., et al. “Temporal trends in the relative prevalence of dysphagia etiologies from 1999- 2009”. World Journal of Gastroenterology 18 (2012): 4335-4341.
  16. Laserna-Mendieta EJ., et al. “Esophageal microbiome in active eosinophilic esophagitis and changes induced by different therapies”. Scientific Reports1 (2021): 1-12.
  17. Weidlich Simon., et al. “IgG4 is elevated in eosinophilic esophagitis but not in gastroesophageal reflux disease patients”. Journal of Clinical Gastroenterology1 (2020): 43-49.
  18. Lecouffe-Desprets Marie., et al. “Eosinophilic gastrointestinal disorders associated with autoimmune connective tissue disease”. Joint Bone Spine5 (2016): 479-484.
  19. Abonia J Pablo., et al. “High prevalence of eosinophilic esophagitis in patients with inherited connective tissue disorders”. Journal of Allergy and Clinical Immunology2 (2013): 378-386.
  20. Putnam PE. “Eosinophilic esophagitis in children: clinical manifestations”. Gastrointestinal Endoscopy Clinics of North America 18 (2008): 11-23.
  21. Sa CC., et al. “Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor”. Clinics 66 (2011): 557-561.
  22. Achem SR., et al. “Oesophageal eosinophilic infiltration in patients with noncardiac chest pain”. Alimentary Pharmacology and Therapeutics 33 (2011): 1194-1201.
  23. Miehlke S. “Clinical features of Eosinophilic esophagitis in children and adults”. Best Practice and Research: Clinical Gastroenterology 29 (2015): 739-748.
  24. Dellon Evan S., et al. “ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE)”. Official Journal of the American College of Gastroenterology ACG5 (2013): 679-692.
  25. Martin Lisa J., et al. “Pediatric Eosinophilic Esophagitis Symptom Scores (PEESS v2. 0) identify histologic and molecular correlates of the key clinical features of disease”. Journal of Allergy and Clinical Immunology6 (2015): 1519-1528.
  26. Albinsson Sofie., et al. “Patient-Reported Dysphagia in Adults with Eosinophilic Esophagitis: Translation and Validation of the Swedish Eosinophilic Esophagitis Activity Index”. Dysphagia (2021): 1-11.
  27. Van Rhijn BD., et al. “Rapidly increasing incidence of eosinophilic esophagitis in a large cohort”. Neurogastroenterology and Motility 25 (2013): 47-52 e5.
  28. Syed AA., et al. “The rising incidence of eosinophilic oesophagitis is associated with increasing biopsy rates: a population-based study”. Alimentary Pharmacology and Therapeutics 36 (2012): 950-958.


Citation: Aimun Raees and Wasim Jafri. “Eosinophilic Esophagitis”. Acta Scientific Gastrointestinal Disorders 4.9 (2021): 18-25.


Copyright: © 2021 Aimun Raees and Wasim Jafri. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate35%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 10, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US